Author | Tahir Latif, MD | OncLive

Author | Tahir Latif, MD


Dr. Tahir Latif on Lower Male Survival Rates in Diffuse Large B-cell Lymphoma

September 22, 2015


Tahir Latif, MD, associate professor of Medicine, interim chief, Division of Hematology Oncology, director, Infusion Services University of Cincinnati Cancer Institute, discusses differences in male survival rates versus female among patients with diffuse large B-cell lymphoma (DLBCL).